Eukaryotic life depends largely on molecular oxygen. During evolution, ingenious mechanisms have evolved that allow organisms to adapt when oxygen levels decrease. Many of these adaptional responses to low oxygen are orchestrated by the heterodimeric transcription factor hypoxia-inducible factor (HIF). Here, we review the link between HIF and apoptosis.
Two to 2.5 billion years ago, earth's atmosphere shifted from an anoxic state to an oxic state, a transition known as the great oxygenation event (5, 24) . This event built the basis of biological diversification as oxygen provided now free energy supply to living organisms. Today's eukaryotes from the humble yeast to highly evolved humans, depend largely on molecular oxygen. Humans for instance can survive only a few minutes without oxygen (47) . Cellular respiration is not only a central but also one of the most sophisticated and elegant aspects of biology. It allows the cell to make use of oxygen's physical properties to exploit the thermodynamic potential of oxidation for energy production.
The key organelle for energy production is the mitochondrion. Mitochondria integrate various metabolic pathways to produce energy for the cell, including the tricarboxylic acid cycle (TCA), betaoxidation, and oxygen metabolism. These metabolic pathways synergize to convert the biochemical energy of nutrients into the cellular energy currency, adenosine triphosphate (ATP). ATP is the main energy form for a variety of cellular processes, including DNA, RNA, and protein synthesis, maintenance of the cytoskeleton, signaling, and ion transport. Moreover, the mitochondrial outer membrane is also critical in the regulation of apoptotic cell death. Thus mitochondria constitute an important crossway between energy production and cell death signaling.
During evolution, oxygen availability became so important that complex anatomical structures were developed to maintain appropriate oxygen delivery to all tissues within an organism. The complex circulatory, respiratory, and neuroendocrine systems were accompanied by mechanisms to sense oxygen levels and adapt to hypoxia at the cellular as well as systemic levels.
Hypoxia is a broad term used for a condition where oxygen demand exceeds oxygen supply. As a result of hypoxia, ATP levels drop, cellular functions cannot be maintained, and-if the insult lasts long enough-cells die. A classical example for an acute hypoxic event is stroke, caused by an occlusion of a brain artery (ischemia: restriction in blood supply) or hemorrhage. A stroke lesion can lead to both types of cell death, necrosis and apoptosis. It is typically characterized by a core of necrosis (56, 104) , a passive, uncontrolled type of cell death. By contrast, the hypoxic stress experienced by cells in the penumbra region that surround the core necrotic region is not sufficient to kill them. These moderately hypoperfused cells, however, subsequently die by apoptosis, a programmed and highly controlled type of cell death that can be pharmacologically blocked (104) . Similar cascades are thought to occur during myocardial infarction, which is also characterized by a core of necrosis and a border zone of the ischemic region, where cells undergo apoptosis (12, 52) .
Why should a hypoxic cell that is not lethally damaged activate apoptosis? What are the molecular mechanisms underlying this decision? Are there adaptational mechanisms to hypoxia that protect from apoptosis? In this review, we cover the effects of hypoxia at the cellular level, discuss adaptational mechanisms to hypoxia, and describe the consequences with regard to apoptotic cell death induction.
Two Paths to Rome: The Intrinsic and the Extrinsic Apoptosis Signaling Pathways
Apoptosis is a cell-intrinsic cell suicide program used by multicellular organisms to eliminate unneeded or potentially dangerous cells in an organism. Whereas apoptosis was initially defined based on characteristic morphological hallmarks, the identification and characterization of the proteins mediating apoptotic cell death led to a more molecular definition (26, 45) . At the molecular level, we can distinguish two major pathways: the intrinsic and extrinsic signaling pathways. The two pathways activate different initiator caspases but converge at the level of effector caspases (FIGURE 1).
The extrinsic signaling pathway is initiated by binding of a death ligand to a death receptor on the cell surface. These death receptors belong to the family of tumor necrosis factor receptor and include TNF-R1, CD95 (Fas), TRAIL-R1, and TRAIL-R2. Binding of CD95 ligand to the CD95, for instance, results in the formation of the CD95 death-inducing signaling complex (DISC) comprised of the FAS-associated death domain (FADD), procaspase-8/procaspase-10, and cellular FLICE-inhibitory protein (c-FLIP) (4) (FIGURE 1) .
In some type of cells (type I cells) that are characterized by high caspase-8 levels, active caspase-8 directly cleaves and activates caspase-3 and other effector caspases. In type II cells, however, caspase-8 levels are lower and the proapoptotic signals need to be amplified by caspase-8 mediated cleavage of the Bcl-2 family member Bid. Truncated (tBid) activates the intrinsic signaling pathway and results in release of cytochrome c from mitochondria (4, 23) .
Intrinsic apoptotic signaling occurs in response to a wide variety of stimuli or cellular stresses such as DNA damage and cytokine deprivation or in response to chemotherapeutic agents. Three interacting subgroups of proteins from the Bcl-2 family control the intrinsic signaling pathway at the mitochondrial membrane (14) . The first group consists of the antiapoptotic Bcl-2 proteins. Members of this subgroup share four conserved Bcl-2 homologous (BH) domains and are essential for cell survival. By contrast, the multi-BH domain pro-apoptotic subfamily members BAX, BAK, and BOK are critical for the effector phase of apoptosis. The third group, the pro-apoptotic BH3-only proteins, shares only the BH3 domain with the other family members. BH3-only proteins are important players in the activation of apoptosis and mediate the response to proapoptotic stimuli such as DNA damage. Upon activation of BH3-only proteins, the balance between antiapoptotic and proapoptotic members shifts.
FIGURE 1. Overview of the intrinsic and extrinsic apoptotic signaling pathways
The binding of a death ligand to the death receptor initiates the extrinsic pathway and results in activation of the death-inducing signaling complex (DISC). Caspase-8 then either directly activates the downstream caspase (type I cells) or needs an amplification step (type II cells) via cleavage of Bid. Intrinsic apoptotic signaling occurs in response to physiological signals or cellular stresses such as DNA damage. Upon activation, the balance between antiapoptotic and proapoptotic Bcl-2 members on the mitochondrial membrane shifts and results in outer mitochondrial membrane permeabilization and cytochrome c release. Bcl-2 family members targeted by HIF are highlighted in red. Cytosolic cytochrome c binds to the apoptotic caspase activating factor (Apaf1) and recruits procaspase-9 to form the apoptosome. Activated caspase-9 within the apoptosome can then promote activation of downstream caspases.
Together, these activities ultimately lead to the activation of Bax and Bak. Some BH3-only proteins such as Bid and Bim directly induce a conformational change of Bax and Bak to form oligomerization (18, 75) . Other BH3 domain proteins bind to and inhibit prosurvival Bcl-2 proteins (102) (FIGURE 1).
Once activated, Bax and Bak mediate mitochondrial outer membrane permeabilization (MOMP) (48, 78, 96) . Mitochondrial outer membrane permeabilization results in the release of a variety of apoptogenic molecules, the most important of which is cytochrome c (57, 70) . Once released to the cytosol, cytochrome c binds in the presence of 2=-deoxyadenosine triphosphate (dATP) or adenosine triphosphate (ATP) to the apoptotic protease activating factor (Apaf1), promoting its oligomerization and the recruitment of the initiator procaspase-9 to form the apoptosome, a wheel-like particle with sevenfold symmetry. Active caspase within the apoptosome then promotes efficient activation of the downstream caspases 3 and 7 that are responsible for the execution phase of apoptosis (1).
Reprogramming Apoptosis Under Hypoxia?

Hypoxia-Inducible Factor, the Master Regulator of the Hypoxic World
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that orchestrates cellular and systemic adaptive responses to maintain oxygen homeostasis and adapt to low oxygen levels. HIF was initially identified as a regulator of erythropoietin gene expression in response to a decrease in oxygen availability in the kidney (94, 95) . The HIF heterodimer consists of an oxygen-dependent ␣-subunit (HIF-1␣, HIF-2␣, or HIF-3␣) and a constitutively expressed ␤-subunit, both of which are basic helix-loop-helix (bHLH) transcription factors. Under normal oxygen levels, prolyl hydroxylases (PHD1-3) utilize oxygen as a substrate to hydroxylate two proline residues of HIF␣ (10, 21, 40, 42) . Hydroxylated HIF␣ is recognized by the von Hippel-Lindau (VHL) protein, which is the substrate recognition subunit of the VCBCul2 ubiquitin-ligase, which ubiquitinates HIF␣ and targets it for proteasomal degradation (103) (FIGURE 2). Under hypoxic conditions, PHD activity decreases, HIF␣ proline residues are not hydroxylated, and the protein can accumulate. Once stabilized, HIF␣ can rapidly enter the nucleus and joins HIF-1␤ to generate the heterodimeric transcription factor HIF, which then promotes the expression of dozens to hundreds of target genes by binding to hypoxia response elements [HRE; minimal core sequence 5=-RCGTG-3= (R is A or G)] present in their regulatory region (98) . A decrease in oxygen levels also leads to impairment of the factor inhibiting HIF (FIH), an asparagine hydroxylase. This impairment results in a decrease in N-803 hydroxylation, which enables recruitment of FIGURE 2. Oxygen-dependent regulation of the heterodimeric transcription factor HIF Under normal oxygen levels, prolyl hydroxylases (PHD) hydroxylate two proline residues (P402 and P564 of HIF-1␣) within the oxygen-dependent degradation domain (ODD) of HIF␣, which allows the binding of the von Hippel Lindau protein (VHL). VHL is the recognition subunit of the VCB-Cul2 ubiquitin ligase, which ubquitinates HIF␣ and results in its rapid degradation. Under low oxygen levels, PHD is not active, and HIF␣ enters the nucleus and activates together with HIF␤ transcription of target genes. A decrease in oxygen levels also leads to impairment of the factor inhibiting HIF (FIH). Impairment of this asparagine hydroxylase results in a decrease in N-803 hydroxylation, which enables recruitment of the transcriptional coactivators p300 and CREB binding protein (p300/CBP).
the transcriptional coactivators p300 and CREB binding protein (p300/CBP) (54, 59) .
Depending on the cellular context, HIF induces the expression of a vast array of genes involved in angiogenesis, cellular metabolism, proliferation, extracellular matrix formation, or the regulation of apoptosis (98) .
HIF␣-Dependent Responses
The effects of a drop in oxygen partial pressure can be basically subdivided in HIF␣-dependent and -independent effects. We start our discussion first with HIF␣-dependent responses.
The consequences of HIF␣ stabilization on apoptosis are complex, exemplified by many opposing reports suggesting that HIF-1␣ can induce as well as antagonize apoptosis. Part of this complexity is due to the existence of three HIF␣ subunits in mammals. HIF-1␣ and HIF-2␣ have overlapping but distinct functions. Depending on the cell type, the two HIF␣ subunits can also have completely opposing effects on apoptosis. Furthermore, HIF␣ subunits can have suppressive interactions as shown in renal cell carcinomas, where enhanced expression of HIF-1␣ suppressed HIF-2␣ and viceversa. Experiments in which expression of one HIF␣ subunit is altered could induce compensatory effects of the other HIF␣ subunits (74, 77) and make it more difficult to draw conclusions. Moreover, the role of HIF-3␣ is less clear. A short splice variant of this gene, the inhibitory PAS protein (iPAS), functions predominantly as transcriptional repressor (62, 63) . HIF-3␣ contains an oxygen-dependent degradation (ODD) domain but no COOH-terminal transactivation domain (CAD). Similar to HIF-1␣ and HIF-2␣, HIF-3␣ is targeted for proteasomal degradation by VHL in an oxygendependent manner (30, 63) . Interestingly, HIF-3␣ can be induced by HIF-1␣, which could be part of a negative feedback loop to attenuate the hypoxia response (60) .
Mitochondria not only contain the electron transport chain but also lie at the center of the intrinsic apoptotic signaling pathway. The two processes overlap at the level of cytochrome c, which not only function in electron transfer between the complexes III and IV but is also released during apoptosis from the mitochondrial intermembrane space (70) . Given the importance of mitochondria in apoptosis regulation, we will start our discussion on HIF␣-mediated effects on apoptosis with the Bcl-2 family members.
HIF␣ subunits have been implicated in the regulation of a variety of Bcl-2 family members with both pro-and antiapoptotic consequences and are summarized in Table 1 . The importance of each of these reported regulatory effects are likely dependent on the cellular context. Proapoptotic changes by HIF-1␣ include downregulation of Bcl-2 (13), induction of BH3-only domain proteins BNIP3 (Bcl2/adenovirus EIB 19kD-interacting protein 3), its homolog Nip-3-like protein 3 (11, 32, 90) , and the BH3-only domain protein Noxa (46) .
In contrast, a large body of evidence suggests that HIF-1␣ can also protect from apoptotic cell death induction (Table 1) . Antiapoptotic changes include increase in Bcl-2 (83) and Mcl-1 levels (58, 71, 89), Bcl-xL induction (16, 64, 83) (through HIF-1␣ binding to a hypoxia-response element in the Bcl-xL promoter), and decreases in pro-apoptotic Bid (22) , Bax (22, 83) , and Bak levels (83) .
Mitochondria could also be directly targeted by HIF-1␣. HIF-1␣ can, for instance, induce mitofusin-1, which changes mitochondrial morphology from a tubular to an enlarged network. Hypoxic cells that were initially resistant to etoposide-induced cell death were resensitized to apoptosis through silencing mitofusin, BNIP3, or BNIP3L (17) . HIF-1␣ has also been linked to mitochondria via hexokinases. Beyond catalyzing the first step of glycolysis, hexokinase II has been reported to shift the apoptotic balance by binding to the voltagedependent anion channel (VDAC) on the mitochondrial membrane (72, 73) . As with many other glycolytic enzymes, hexokinase II can be induced by HIF-1␣, and a recent study indicated that hexokinase II is crucial for the Warburg effect in glioblastoma multiforme (101) . This direct interaction, most probably independent of Bax and Bak (53, 61, 79, 101) , could therefore integrate the preferential use of aerobic glycolysis (Warburg effect) with the inhibition of apoptosis.
The impact of HIF-2␣ on apoptotic cell death induction has been studied to a smaller extent but points clearly to an antiapoptotic function. Raval and colleagues have shown that HIF-2, in contrast to HIF-1, negatively regulates pro-apoptotic BNIP3 in VHL-deficient renal cell carcinomas cells (77) . Although the impact on apoptosis has not been tested in this study, the authors elegantly showed that the two HIF␣ subunits have contrasting biological properties, with HIF-1␣ retarding and HIF-2␣ enhancing renal cell tumor growth, a feature that could be partly due to differential apoptosis regulation. Another study dissected the HIF-1␣ and HIF-2␣ network in hepatocellular carcinoma cells. In this system, HIF-1␣ knockdown also increased expression of HIF-2␣ and vice-versa. Moreover, HIF-2␣ expression shifted the balance of the Bcl-2 family members toward survival (64) . Finally, the short splice variant of HIF-3 (IPAS) has been been implicated in exerting a proapoptotic activity by direct binding to Bcl-x(L) (92).
p53 and HIF: Communications Among Master Regulators
p53 is a tumor suppressor that can signal to the intrinsic apoptosis pathway. Following activation, p53 can induce proapoptotic BH3-only proteins such as Puma and Noxa to trigger apoptosis. The interaction between HIF␣ and p53 has been the source of much controversy in the past. As is the case for VHL and HIF␣, p53 is tightly controlled and targeted for proteasomal degradation by its ubiquitin ligase Mdm2. Activation of p53 includes posttranslational modifications at the NH 2 terminus that disrupt the interaction with Mdm2 and results in p53 accumulation and transcriptional activation of p53 target genes by recruitment of p300/CBP (67, 69, 93) .
At least three different types of interaction have been proposed between HIF-1␣ and p53. First, direct protein-protein interaction has been proposed as the underlying mechanism for hypoxia-induced p53 stabilization (3) . Two different studies have provided in vitro data suggesting a direct binding of the ODD (oxygen-dependent degradation) domain of HIF-1␣ to p53 (37, 82) . Moreover, direct in vitro and in vivo interactions between HIF-1␣ and Mdm2 to modulate p53 function (15) and VHL and p53 association to stabilize p53 have been reported (81) . Thus, if HIF␣ and p53 were simultaneously stabilized, direct interaction between these two proteins could affect transcription of p53 target genes. However, these data have been challenged by a report that HIF-1␣ was not required for p53 induction under hypoxia (97) . Another controversy to this scenario has been that HIF-1 is induced at relatively modest hypoxia levels, whereas p53 is only stabilized under severe hypoxia, restricting possible interactions. Moreover, although phosphorylated HIF-1 is bound to HIF-1␤, only dephosphorylated HIF-1␣ seems to be able to bind p53 and promote apoptosis (91) .
Second, given that both transcription factors require p300/CBP as coactivator, it has been suggested that p53 and HIF␣ compete for p300/CBP (85) . In such a scenario, stabilized HIF␣ could outcompete p53 from p300 and attenuate the transcriptional response to p53. Third, the network of HIF-1␣ target genes could directly or indirectly affect p53 response. A number of HIF-1 targets, including homeodomain-interacting protein kinase-2 (HIPK2) (68) or nucleophosmin (55) , have been implicated in negatively regulating p53-induced apoptosis. Of course, all these processes could occur simultaneously, further complicating the picture.
Whereas HIF-1␣ seems to have context-dependent pro-and antiapoptotic functions, HIF-2␣ predominantly inhibits p53. First, unlike HIF-1␣, HIF-2␣ does not bind Mdm2 (7) . In renal cell carcinoma cells, inhibition of HIF-2␣ has been shown to promote p53 phosphorylation and stabilization likely due to an increase in ROS generation and DNA damage. Another mechanism for HIF-2␣-induced p53 inhibition in renal cell carcinomas might include phosphorylation and nuclear accumulation of Mdm2, resulting in enhanced degradation of p53 (80) . This antiapoptotic function of HIF-2␣ is indirectly mediated through AKT-mediated phosphorylation of Mdm2, suggesting that HIF-2␣ could negatively affect clinical response to radiotherapy and chemotherapy (80) .
Interestingly, stabilization of p53 under low oxygen conditions results in a different type of activity than when induced by DNA damage. Extensive microarray analyses showed that, unlike DNA damage, hypoxia resulted in stabilized p53 with mainly transrepression activity (35, 51) . The proapoptotic p53 targets such as Puma, Noxa, and Bax are elevated in response to DNA damage, but not hypoxia, likely due to interaction with mSin3A instead of p300 (35, 51) .
In summary, the net effects of HIF stabilization on apoptosis signaling are clearly context-dependent. Although HIF-1␣ can either have pro-or antiapoptotic properties, HIF-2␣ seems to predominantly activate a signaling network antagonizing apoptosis. These distinct outcomes could be explained by different cellular contexts in which HIF is stabilized: although it might be beneficial to eliminate a damaged, potentially harmful cell under hypoxia, an endothelial cell under low oxygen levels, for instance, needs to proliferate and be protected from apoptosis to ensure neovascularization.
HIF␣-Independent Responses
During hypoxia, reactive oxygen species can be generated (33) due to electron release before transfer to complex IV (87) . This leads to DNA damage (34) , opening of the mitochondrial permeability transition pore (20, 38) , and release of apoptogenic proteins such as cytochrome c. Furthermore, ATM and ATR kinases are phosphorylated under low oxygen levels independently of DNA damage and HIF-1 (6), with the possible result that these ki- (49, 65, 100) or homologous recombination proteins (8, 9) are inhibited under hypoxia. The resulting genetic instability can either amplify an already present proapoptotic signal or independently trigger apoptosis. These responses are likely dependent on the severity of oxygen deprivation and on the specific cellular context. Some of these pathways are only activated by severe hypoxia or anoxia (Ͻ0.2% O 2 ), as shown, for instance, for p53 activation. For example, although HIF-1␣ was stabilized at 2% O 2 , p53 only accumulated at 0.02% O 2 , suggesting that mild and severe oxygen levels might activate different signaling networks with different apoptotic outcomes (2, 34) .
Therefore, a drop in oxygen partial pressure can on one hand activate several upstream players of the intrinsic apoptosis pathway. On the other hand, episodes of reoxygenation (ischemia reperfusion injury) following hypoxic exposure can induce additional DNA damage. Together, these effects result in an activation of apoptotic signaling, which, if not opposed, will ultimately lead to apoptotic cell death.
Hypoxia-Inducible Factor and Apoptosis in Lower Organisms
The roundworm C. elegans has been a powerful model to elucidate the molecular basis of apoptosis. The core apoptotic machinery in C. elegans consists of the Bcl-2 homolog CED-9, which prevents, under normal conditions, CED-4 (Apaf1) from activating the effector caspase CED-3 (31). Apoptosis is triggered by the BH3-only domain protein EGL-1, which binds to the CED-9-CED-4 complex at the mitochondrial membrane, thereby releasing CED-4 (19, 39) . Once released from the complex, CED-4 forms an octamer to facilitate autocatalytic activation of CED-3 (76) . Of the 1,090 cells generated during development, 131 die by apoptosis. In the adult hermaphrodite germ line, the same apoptotic execution machinery mediates the removal of approximately half of all presumptive oocytes (31) . Apoptosis in the germ line can be induced by DNA damage through a conserved signaling pathway that leads to activation of the p53 homolog CEP-1 and transcriptional upregulation of EGL-1 by CEP-1/p53 (27) .
Although this tiny nematode consists of only 959 somatic cells and contains no specialized system for oxygen delivery, it still expresses a single isoform of the hypoxia-inducible factor HIF-1 (43) . C. elegans might need an efficient hypoxia response system since it inhabits the soil environment, where oxygen levels can vary from 21% to virtually 0%. Thus C. elegans is exposed to the whole spectrum of oxygen levels and will require efficient adaptational mechanisms to protect its cells.
HIF-1 in C. elegans is clearly an antiapoptotic factor. vh-1 or egl-9 mutant worms, both of which show constitutively stabilized HIF-1 levels, completely fail to induce DNA damage-induced germline apoptosis (88) . HIF-1 inhibits either directly or indirectly CEP-1/p53, whereas the function of the BH3-only domain protein EGL-1 and the Bcl-2 member CED-9 is not affected. Thus the various levels of interaction seen in mammals (Bcl-2 family, BH3-only domain proteins, p53) is reduced and simplified in the worm to the inhibition of p53.
Curiously, HIF-1 controls programmed cell death in C. elegans non-cell-autonomously by promoting expression of the tyrosinase family member called TYR-2. TYR-2 is a secreted protein and acts as a critical negative regulator of p53-dependent germline apoptosis. It is interesting to note that this neuronally controlled, systemic hypoxia response is reminiscent of the mammalian carotid body, which similarly translates a drop in oxygen partial pressure into a systemic adaptation. Non-cellautonomous control of apoptosis by hypoxia has not been reported so far in mammals. Nevertheless, several secreted hypoxia-inducible gene products have been extensively characterized (e.g., erythropoietin, VEGF), and it will be very interesting to see whether mammalian tissues have similar non-cell-autonomous factors to inhibit apoptosis.
In Drosophila, the HIF␣ homolog termed Sima has also been reported to promote survival. Crystal cells are a specific type of blood cells produced by the Drosophila lymph gland, which functions in clotting and wound healing. These blood cells have been shown to express even under normoxic conditions the Sima protein, which acts as a critical factor for hemocyte survival during development and hypoxic stress. Intriguingly, hemocyte survival is independent of the HIF␤ homolog Tango, requiring instead activation of Notch signaling (66) .
HIF and Apoptosis in Physiological and Pathophysiological Conditions
Although flies and worms mutant in HIF␣ are viable, mice embryos deficient in HIF-1␣ die at day E11 due to multiple defects, including cell death within the cephalic mesenchyme as well as within the endothelial and supporting mesenchyme, which leads then to vascular defects (41, 50) . Although a direct involvement of apoptotic signaling pathways has not been reported so far, it is possible that HIF␣ supports survival during development partly also via protection from apoptosis. Another physiological role for HIF-1␣ in inhibition of cell death has been reported in chondrocytes (84) . In mammals, the cartilaginous growth plate of developing bone is an avascular, hypoxic tissue. Chondrocytes that lack HIF-1␣ undergo massive apoptosis, suggesting that HIF-1␣ acts also during bone development as a critical survival factor (84) .
It is noteworthy that hypoxia signaling can also be hijacked, for instance, by pathogens. For example, the obligate intracellular bacterium Chlamydia trachomatis developed a very elegant strategy to guarantee its own survival. Chlamydia infections result during the early time points in stabilization of HIF-1␣ within the host cell and a subsequent transcriptional activation of the anti-apoptotic Bcl-2 family member Mcl-1 (89) . Thus Chlamydia trachomatis protects infected host cells from undergoing apoptosis by adopting part of the molecular machinery that ensures cellular survival under hypoxia.
Implications for Cancer Therapy
Apoptosis is a process that links both cancer genetics and cancer therapy. Evading apoptosis is a hallmark of cancer (36) . Similarily, the ability to trigger apoptosis is a major determinant of therapy response since many chemotherapies activate pathways that ultimately converge on a common apoptotic signaling pathway (44) .
Most solid tumors have heterogenous oxygen supply and contain regions that are hypoxic. Tumor hypoxia has been associated with radioresistance more than half a century ago (29) , and increased HIF␣ levels have been associated with increased mortality in many studies since (86) . There are numerous HIF target genes that have been implicated in tumorigenesis, including CXCR, VEGF, PDGF, or TGF-␤. In parallel to oncogene activation, regulation of apoptosis by HIF will have a major effect on tumorigenesis as well as on cancer therapy. Therefore, a comprehensive analysis of signaling pathways linking HIF and apoptosis could help in understanding why HIF stabilization is associated with higher mortality and treatment failure in many tumor types. Last but not least, these signaling pathways could represent interesting targets for cancer therapy. 
